Covid rates in India and Brazil are quite serious.
Post# of 36537
(Total Views: 271)
Posted On: 05/13/2021 6:36:01 AM
Covid rates in India and Brazil are quite serious. CYDY is starting a trial with leronlimab in Brazil and is in discussions with India.
Joe mentioned on the last CC our vaccine trial may be studied outside the US if I recall correctly. Do we have an idea where? Best to go where the rate of infection is high and costs to run trials are less expensive than in the US. Also working with countries that are not 100% dependent on the US FDA can be a benefit. Obviously the vaccine will be studied in China but I do not know if that is what Joe meant. Perhaps Malaysia.
Joe mentioned on the last CC our vaccine trial may be studied outside the US if I recall correctly. Do we have an idea where? Best to go where the rate of infection is high and costs to run trials are less expensive than in the US. Also working with countries that are not 100% dependent on the US FDA can be a benefit. Obviously the vaccine will be studied in China but I do not know if that is what Joe meant. Perhaps Malaysia.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼